Galectin Therapeutics Inc. (GALT) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$3.09
Day's range
$3.47

Galectin Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK, INC. 08/07/2026 2.99 M $13.87 M   273.90% 4.54%
VANGUARD CAPITAL MANAGEMENT LLC 08/13/2026 2.17 M $10.06 M   10.25% 3.30%
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 1.31 M $6.07 M   113.52% 1.99%
ADVISOR GROUP HOLDINGS, INC. 08/14/2026 1.20 M $5.59 M   7.22% 1.83%
MARSHALL WACE, LLP 08/13/2026 831.01 K $3.86 M   -31.88% 1.26%
GREAT POINT PARTNERS LLC 08/14/2026 800.00 K $3.71 M   0.00% 1.22%
WEALTHSPIRE ADVISORS, LLC 08/11/2026 721.79 K $3.35 M   0.00% 1.10%
STATE STREET CORP 08/07/2026 567.78 K $2.63 M   119.70% 0.86%
COMMONWEALTH EQUITY SERVICES, LLC 07/29/2026 407.11 K $1.89 M   10.90% 0.62%
NORTHERN TRUST CORP 08/13/2026 386.55 K $1.79 M   196.32% 0.59%
VANGUARD FIDUCIARY TRUST CO 08/13/2026 366.48 K $1.70 M   20.46% 0.56%
VANGUARD PORTFOLIO MANAGEMENT LLC 08/13/2026 327.77 K $1.52 M   100.00% 0.50%
TWO SIGMA INVESTMENTS, LP 08/14/2026 318.25 K $1.48 M   -31.86% 0.48%
LPL FINANCIAL LLC 08/07/2026 285.38 K $1.32 M   6.80% 0.43%
SOVRAN ADVISORS, LLC 07/30/2026 258.00 K $874.61 K   0.06% 0.39%
GENEOS WEALTH MANAGEMENT INC. 08/06/2026 240.43 K $1.12 M   -0.21% 0.37%
UBS GROUP AG 08/13/2026 219.32 K $1.02 M   22.02% 0.33%
CITADEL ADVISORS LLC 08/14/2026 211.60 K $981.82 K   426.37% 0.32%
RETIREMENT GUYS FORMULA LLC 07/30/2026 211.05 K $979.29 K   12.83% 0.32%
CITADEL ADVISORS LLC 08/14/2026 198.70 K $921.97 K   -31.57% 0.30%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 08/14/2026 177.20 K $822.19 K   -68.11% 0.27%
NATIONAL BANK OF CANADA /FI/ 08/10/2026 167.90 K $779.06 K   100.00% 0.26%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 08/14/2026 151.00 K $700.64 K   -68.10% 0.23%
BLAIR WILLIAM & CO/IL 08/11/2026 149.28 K $692.67 K   0.00% 0.23%
CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. 07/30/2026 130.65 K $606.00 K   1.55% 0.20%
CITADEL ADVISORS LLC 08/14/2026 128.70 K $597.17 K   292.38% 0.20%
GSA CAPITAL PARTNERS LLP 08/06/2026 128.66 K $597.00 K   80.14% 0.20%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 08/14/2026 116.42 K $540.21 K   287.95% 0.18%
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. 08/14/2026 116.42 K $540.21 K   100.00% 0.18%
BANK OF NEW YORK MELLON CORP 08/06/2026 105.74 K $490.64 K   100.00% 0.16%
HIGHTOWER ADVISORS, LLC 08/05/2026 94.13 K $436.74 K   0.80% 0.14%
MORGAN STANLEY 08/13/2026 93.48 K $433.72 K   -10.47% 0.14%
SIMPLEX TRADING, LLC 08/12/2026 83.25 K $386.28 K   -0.89% 0.13%
GOLDMAN SACHS GROUP INC 08/14/2026 74.55 K $345.93 K   -59.64% 0.11%
HOPWOOD NICHOLAS HUNTER 08/14/2026 69.30 K $321.53 K   0.00% 0.11%
TRUIST FINANCIAL CORP 07/28/2026 68.00 K $315.52 K   0.00% 0.10%
NUVEEN, LLC 08/11/2026 63.71 K $295.61 K   100.00% 0.10%
BANK OF AMERICA CORP /DE/ 08/14/2026 57.72 K $267.80 K   7.15% 0.09%
RHUMBLINE ADVISERS 08/12/2026 48.33 K $224.26 K   100.00% 0.07%
DEUTSCHE BANK AG\ 08/07/2026 47.40 K $219.95 K   100.00% 0.07%
HORIZON KINETICS ASSET MANAGEMENT LLC 08/11/2026 46.97 K $217.93 K   -4.59% 0.07%
WELLS FARGO & COMPANY/MN 08/14/2026 46.69 K $216.65 K   641.24% 0.07%
RENAISSANCE TECHNOLOGIES LLC 08/13/2026 43.34 K $201.11 K   -70.69% 0.07%
SANCTUARY ADVISORS, LLC 08/13/2026 41.73 K $193.63 K   -3.59% 0.06%
PINNACLE FINANCIAL PARTNERS, INC. 08/14/2026 41.65 K $193.26 K   0.00% 0.06%
CAPTION MANAGEMENT, LLC 08/14/2026 40.00 K $185.60 K   0.00% 0.06%
PRICE T ROWE ASSOCIATES INC /MD/ 08/14/2026 39.31 K $183.00 K   100.00% 0.06%
JPMORGAN CHASE & CO 08/12/2026 37.19 K $184.83 K   236.76% 0.06%
MILLENNIUM MANAGEMENT LLC 08/14/2026 35.86 K $166.40 K   -95.51% 0.05%
PEKIN HARDY STRAUSS, INC. 07/30/2026 30.00 K $139.20 K   0.00% 0.05%

Galectin Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 151 institutional investors and hedge funds held shares of Galectin Therapeutics Inc. The most heavily invested institutionals were:

BlackRock, Inc.: 2.99 M

VANGUARD CAPITAL MANAGEMENT LLC: 2.17 M

GEODE CAPITAL MANAGEMENT, LLC: 1.31 M

ADVISOR GROUP HOLDINGS, INC.: 1.2 M

MARSHALL WACE, LLP: 831,010

Wealthspire Advisors, LLC: 721,788

23.94% of Galectin Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 21.50 M shares in the last 24 months. This purchase volume represents approximately $72.02 M in transactions.